难治性胃轻瘫患者经口内镜下幽门肌切开术治疗后的结局预测因素:一项系统综述
该系统综述纳入30项研究,评估难治性胃轻瘫患者接受胃经口内镜下幽门肌切开术(GPOEM)后临床与功能应答的预测因素。GPOEM应答率为63.1%(95%CI 56.3%-69.5%),多数研究以胃轻瘫主要症状指数改善定义临床成功(87%,26/30)。多因素分析显示高龄、胃轻瘫病程较短、非糖尿病病因、较低体重指数及幽门内肉毒毒素注射应答与阳性应答相关,而EndoFLIP或胃排空闪烁显像等生理测试的预测因素不一致,尚无预后模型经过外部验证。
要点
- GPOEM应答率为63.1%(95%CI 56.3%-69.5%),87%(26/30)研究以胃轻瘫主要症状指数改善定义临床成功。
- 多因素分析中,高龄、病程较短、非糖尿病病因、较低体重指数及幽门内肉毒毒素应答与阳性应答相关。
- EndoFLIP或胃排空闪烁显像等生理测试的预测因素不一致,尚无预后模型经过外部验证。
核心结论
- 目前难治性胃轻瘫患者对GPOEM应答的可重复预测因素有限。
- 需要稳健的前瞻性研究探究可扩展、可重复且可操作的疗效应答生物标志物。
研究设计与样本
- 系统综述,检索MEDLINE、Embase和CENTRAL数据库(截至2023年9月),纳入30项研究。
- 纳入成人胃轻瘫患者接受GPOEM后报告结局的研究,采用叙述性综合评估单因素和多因素分析中的预测因素。
- 通过Meta分析评估应答率,并使用ROBINS-E进行偏倚风险评估(PROSPERO注册号:CRD42023457359)。
主要发现
- 共审查1899篇文章,最终纳入30项研究。
- GPOEM应答率为63.1%(95%CI 56.3%-69.5%)。
- 87%(26/30)的研究基于胃轻瘫主要症状指数改善定义临床成功。
- 多因素分析显示高龄、胃轻瘫病程较短、非糖尿病病因、较低体重指数及幽门内肉毒毒素注射应答与GPOEM阳性应答相关。
- EndoFLIP或胃排空闪烁显像等生理测试的预测因素不一致。
关键数值与推荐
- GPOEM应答率63.1%(95%CI 56.3%-69.5%)。
- 临床成功定义:87%(26/30)的研究基于胃轻瘫主要症状指数改善。
- 多因素分析中与阳性应答相关的因素:高龄、病程较短、非糖尿病病因、较低体重指数、幽门内肉毒毒素注射应答。
- 生理测试(EndoFLIP或胃排空闪烁显像)的预测因素不一致。
- 无预后模型经过外部验证。
临床怎么用
- 原文未据此给出推荐。
局限性
- 目前难治性胃轻瘫患者对GPOEM应答的可重复预测因素有限。
- 尚无预后模型经过外部验证。
- 需要稳健的前瞻性研究探究可扩展、可重复且可操作的疗效应答生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Gastroparesis is a debilitating gastroduodenal disorder for which gastric peroral endoscopic myotomy (GPOEM) has emerged as an efficacious treatment option. However, response to GPOEM varies between 50% and 80%, such that preoperative predictors of treatment success are needed to guide patient selection. METHODS: We performed a systematic review to identify predictors of clinical and functional response to GPOEM among adult patients with gastroparesis (PROSPERO: CRD42023457359). MEDLINE, Embase, and CENTRAL databases were searched systematically for studies reporting outcomes after GPOEM in September 2023. A narrative synthesis of predictive factors on univariable and multivariable analysis was performed with consideration of response rates through meta-analysis and evaluation of discrimination if prognostic models were developed. Risk Of Bias In Non-randomized Studies - of Exposures (ROBINS-E) was used for risk of bias assessment. RESULTS: Of 1899 articles reviewed, 30 were included. The GPOEM response rate was 63.1% (95% confidence interval 56.3%-69.5%) with most studies defining clinical success on the basis of improvement in gastroparesis cardinal symptom index (87%, 26/30). Older age, shorter duration of gastroparesis, nondiabetic etiology, lower body mass index, and response to intrapyloric botulinum toxin were associated with positive response to GPOEM on multivariable analyses. Predictors on physiological tests such as EndoFLIP or gastric emptying scintigraphy were inconsistent. No prognostic models underwent external validation. DISCUSSION: Currently, there are limited reproducible predictors of response to GPOEM among patients with refractory gastroparesis. Robust prospective studies investigating scalable, reproducible, and actionable biomarkers of treatment response are required.
引用
- Varghese C, Lim A, Daker C, et al. Predictors of Outcomes After Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis: A Systematic Review. Am J Gastroenterol. 2024. PMID: 39733275. doi:10.14309/ajg.0000000000003213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。